Dasher Neuroscience Holdings (ROCO:7829) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7829 Dasher Neuroscience Holdings Inc ROCO:7829
14 GF Score
Price NT$39.00
! 2 Warning Signs
View Full Analysis

What is Dasher Neuroscience Holdings FCF Margin %?

Dasher Neuroscience Holdings ROCO:7829 -2.86% 14 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:7829 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 963 Drug Manufacturers companies, Dasher Neuroscience Holdings ranks worse than 103842.06% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dasher Neuroscience Holdings's Free Cash Flow for the six months ended in Dec. 2025 was NT$-134.58 Mil. Dasher Neuroscience Holdings's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, Dasher Neuroscience Holdings's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Dasher Neuroscience Holdings's current FCF Yield % is -9.13%.

The historical rank and industry rank for Dasher Neuroscience Holdings's FCF Margin % or its related term are showing as below:


ROCO:7829's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.55
* Ranked among companies with meaningful FCF Margin % only.

Dasher Neuroscience Holdings FCF Margin % Related Terms

Dasher Neuroscience Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for Dasher Neuroscience Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dasher Neuroscience Holdings FCF Margin % Chart

Dasher Neuroscience Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 0.00 0.00

Dasher Neuroscience Holdings Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ROCO:7829 vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dasher Neuroscience Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dasher Neuroscience Holdings FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dasher Neuroscience Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dasher Neuroscience Holdings's FCF Margin % falls into.


ROCO:7829
14GF Score
Dasher Neuroscience Holdings Inc ROCO:7829
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dasher Neuroscience Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dasher Neuroscience Holdings's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-353.783/0
= %

Dasher Neuroscience Holdings's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-134.58/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Dasher Neuroscience Holdings (ROCO:7829) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dasher Neuroscience Holdings and its competitors. According to the industry distribution chart, Dasher Neuroscience Holdings ranks #999999 out of 963 companies in the Drug Manufacturers industry.
Is Dasher Neuroscience Holdings' FCF Margin % too high?
Dasher Neuroscience Holdings' current FCF Margin % is 0.00%. Based on the distribution chart, Dasher Neuroscience Holdings ranks #999999 out of 963 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dasher Neuroscience Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Dasher Neuroscience Holdings' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dasher Neuroscience Holdings ranks #999999 out of 963 companies for FCF Margin %. This places Dasher Neuroscience Holdings in the lower half of its industry. The industry median FCF Margin % is 2.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.55, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dasher Neuroscience Holdings and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dasher Neuroscience Holdings's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dasher Neuroscience Holdings stock overvalued right now?
Dasher Neuroscience Holdings (ROCO:7829) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Dasher Neuroscience Holdings' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dasher Neuroscience Holdings (ROCO:7829), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dasher Neuroscience Holdings Business Description

Address Park Street, 17th Floor., No.3, Nangang District, Taipei, TWN, 115603
Yoda Pharmaceuticals Inc is a pharmaceutical company specializing in using AI technology to develop drugs targeting Central Nervous System (CNS) disorders. The group provides solutions for Neurology, Neuropsychiatry, and Cerebrovascular Disease.
14GF Score

Get the complete analysis for ROCO:7829

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$39.00
Price